Researchers seek to quantify immunogenicity of COVID vaccines in immunocompromised patients

By | July 2, 2021
Evidence continues to mount that vaccination against COVID-19, most notably the Pfizer and Moderna vaccines, produces robust, durable protection in the vast majority of recipients.